Castellum (CTM) Q2 2026 earnings review
Growth Narrative Masks a Q2 Stall and Profitability Squeeze
Management highlighted a 10% H1 revenue increase, but zeroed in on Q2 alone, the growth story is reversing. Q2 2026 revenue came in at $13.86M, down slightly YoY (-1%) and sequentially vs Q1 ($14.29M). More alarmingly, the bottom line collapsed: Gross margin compressed to 34.0%, and Adjusted EBITDA practically vanished to $26K (down 95% from $500K a year ago). The culprit? A higher mix of low-margin subcontractor work, costs to complete firm-fixed-price contracts, and heavy front-loaded investments in business development and M&A. While a debt-free balance sheet and a $271.7M backlog offer long-term stability, Castellum is currently sacrificing near-term profitability to chase its Phase 3 expansion strategy.
🐂 Bull Case
The company fully eliminated its debt in Q1 and funded operations entirely from operating cash flow in H1, growing its cash reserve to $16.9M. This provides a fortress balance sheet to support M&A without dilution.
Total backlog remains healthy at $271.7M, and the qualified pipeline expanded sequentially to $953.5M. Recent wins like the $4.0M Navy ADMACS and a position on the $250M LIIS CMDS MAC validate the company's competitive positioning.
🐻 Bear Case
Gross margins are compressing (34% vs 36% YoY) due to an unfavorable mix of lower-margin subcontractor work and cost overruns on remaining firm-fixed-price contracts. Adjusted EBITDA essentially wiped out.
Despite management touting H1 growth, Q2 standalone revenue actually declined YoY by 1% to $13.86M. The ramp-up of new prime contracts was completely offset by the wind-down of legacy work.
⚖️ Verdict: 🔴
Bearish. The PR headlines focus on H1 growth, but Q2 standalone shows flatlining revenue and collapsing margins. Firm-fixed-price contracts and subcontractor mix issues are destroying operating leverage.
Key Themes
Gross Margin Hit by Firm-Fixed-Price Contracts
Gross margin decelerated to 34.0% in Q2 from 36.0% a year ago and 35.4% in Q1. The company explicitly cited the 'cost to complete the remaining work on two firm-fixed-price contracts' alongside a higher mix of subcontractor work. In federal contracting, fixed-price contracts shift inflation and execution risk to the contractor, directly penalizing profitability when costs overrun.
Operating Leverage Reversing as Expenses Surge
Adjusted EBITDA plunged to just $26K (from $500K YoY). This collapse is driven by 'front-loaded' investments in business development, investor relations, and M&A activities. General & Administrative (G&A) expenses climbed to $2.87M, up from $2.73M last year. While management insists these investments will drive multi-year growth, current shareholders are bearing the brunt of the immediate margin destruction.
Q2 Top-Line Momentum Stalls
Revenue growth is reversing. Q1 posted a 23% YoY gain, but Q2 came in at $13.86M, representing a 1% YoY decline. Management attributed this to the 'expected wind down of certain contracts' offsetting the ramp-up of the SSI NAWCAD Lakehurst contract. This directly contradicts the overarching 'growth' narrative and places immense pressure on H2 execution to achieve full-year records.
PMA-290 and NAWCAD Lakehurst Driving Base Work
The primary drivers for H1's overall 10% revenue growth are the long-term prime contracts won in 2025, specifically the NAVAIR PMA-290 Special Missions program and the NAWCAD Lakehurst MO&I award. The company is leaning heavily on these anchors to generate the base operating cash flow needed to fund its aggressive BD expansion.
CMMC Level 2 Certification Opens Doors
Castellum successfully achieved Cybersecurity Maturity Model Certification (CMMC) Level 2. In the DoD contracting macro environment, this is a critical barrier to entry. This validation allows Castellum to aggressively bid on restricted defense programs and serve as a prime contractor on sensitive data networks, directly supporting its $953.5M pipeline.
Fortress Balance Sheet Ready for M&A
The company's financial footing has stabilized significantly. After eliminating related-party notes in Q1, Castellum ended Q2 entirely debt-free with $16.9M in cash (up from $14.9M at the end of FY25). This liquidity profile allows management to selectively pursue M&A 'through the cycle rather than react to it,' targeting specific contract vehicles and customer access.
Other KPIs
Accelerating. Up from $938.0M in Q1 2026 and $817M at the end of Q1 2025. This metric reflects the aggressive business development investments the company is currently making at the expense of near-term EBITDA.
Stable. The company funded H1 entirely from operations, adding $2.0M to the cash balance since year-end 2025. This signals that despite the GAAP net loss of $(1.38)M for H1, working capital management and non-cash add-backs (like the $1.56M in stock-based compensation) are keeping cash flow positive.
Guidance
Accelerating implicitly. Management reiterated expectations for full-year 2026 to be a record. FY25 total revenue was $52.87M. With H1 2026 at $28.16M, Castellum needs approximately $24.7M in H2 to break the record, requiring roughly $12.35M per quarter—a low bar given the $13.86M Q2 run rate.
Stable. The company expects to recognize ~16% of its $271.7M backlog (roughly $43.5M) over the next 12 months, and ~48% over the next 24 months. This implies a steady revenue baseline of ~$10.8M per quarter locked in, meaning BD efforts must convert to fill the gap to the current ~$14M quarterly run rate.
Key Questions
Firm-Fixed-Price Exposure
You noted margin drag from completing two firm-fixed-price contracts. What is the remaining duration and financial liability on these specific contracts, and when will they cleanly roll off the P&L?
Subcontractor Mix
The higher mix of lower-margin subcontractor work impacted gross profits this quarter. Is this mix structural to the new NAWCAD Lakehurst and PMA-290 awards, or is it temporary while you hire direct labor?
Return on BD Investments
You are trading near-term EBITDA for front-loaded BD and M&A investments. What are the specific internal KPIs or timeline markers you are using to measure the ROI on these elevated G&A expenses?